Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations. Local targets link to admitted publications; unresolved targets remain external evidence.
Integrating cannabis into clinical cancer care
10.3747/co.23.3099 · 2016 · External reference
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer
10.18632/oncotarget.10087 · 2016 · External reference
Curcumin, its derivatives, and their nanoformulations: revolutionizing cancer treatment
10.1002/cbf.3911 · 2024 · External reference
Structure-antioxidant activity relationships of Luteolin and Catechin
10.1111/1750-3841.14994 · 2020 · External reference
Vitamin C: a comprehensive review of its role in health, disease prevention
10.3390/molecules30030748 · 2025 · External reference
Quercetin derivatives: drug design, development, and biological activities, a review
10.1016/j.ejmech.2021.114068 · 2022 · External reference
The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo
10.1097/mpa.0b013e318264ccae · 2013 · External reference
Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells
10.1111/j.1440-1746.2011.07000.x · 2012 · External reference
Pancreatic cancer: the microenvironment needs attention too
10.1016/j.pan.2015.02.013 · 2015 · External reference
Unresolved reference
External reference
Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3’-kinase activity
10.1158/0008-5472.can-03-3104 · 2004 · External reference
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
10.1200/jco.2020.38.4_suppl.824 · 2020 · External reference
Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells
10.1007/s10637-008-9183-7 · 2009 · External reference
Recent advancements in bioactive natural products and nanoparticle-mediated drug delivery in cancer therapy
10.3390/ijms27031356 · 2026 · External reference
Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin
10.2147/cmar.s161824 · 2018 · External reference
Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer
10.1155/2013/810423 · 2013 · External reference
Genetic mutations associated with cigarette smoking in pancreatic cancer
10.1158/0008-5472.can-09-0015 · 2009 · External reference
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer
10.1007/s10637-008-9184-6 · 2009 · External reference
NADH autofluorescence, a new metabolic biomarker for cancer stem cells: identification of vitamin C and CAPE as natural products targeting “stemness.”
10.18632/oncotarget.15400 · 2017 · External reference
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
10.1158/1055-9965.epi-07-0022 · 2007 · External reference
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
10.1093/annonc/mdr541 · 2012 · External reference
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
10.1038/s41575-019-0245-4 · 2020 · External reference
Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer
10.1073/pnas.73.10.3685 · 1976 · External reference
Quercetin mediates β-Catenin in pancreatic cancer stem-like cells
10.1097/mpa.0000000000000400 · 2015 · External reference
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
10.1158/0008-5472.can-06-0169 · 2006 · External reference
Curcumin on the “flying carpets” to modulate different signal transduction cascades in cancers: next-generation approach to bridge translational gaps
10.1002/jcb.26749 · 2018 · External reference
Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer
10.7150/thno.51265 · 2021 · External reference
Role of immune cells in pancreatic cancer from bench to clinical application: an updated review
10.1097/md.0000000000005541 · 2016 · External reference
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer
10.1053/j.gastro.2007.10.040 · 2008 · External reference
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
10.1073/pnas.0702854104 · 2007 · External reference
Cytotoxin-associated gene A-Negative strains of Helicobacter pylori as a potential risk factor of pancreatic cancer: a meta-analysis based on nested case-control studies
10.1097/mpa.0000000000000414 · 2015 · External reference
Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo
10.4161/cc.24445 · 2013 · External reference
The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells
10.1016/j.canlet.2014.08.019 · 2014 · External reference
Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case-control study
10.1136/bmjopen-2011-000397 · 2011 · External reference
FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer
10.1056/nejmoa1809775 · 2018 · External reference
Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial
10.1001/jamaoncol.2022.3829 · 2022 · External reference
Quercetin and ferroptosis
10.3390/life13081730 · 2023 · External reference
Natural anti-cancer products: insights from herbal medicine
10.1186/s13020-025-01124-y · 2025 · External reference
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
10.1038/cddis.2013.151 · 2013 · External reference
Phase II trial of curcumin in patients with advanced pancreatic cancer
10.1158/1078-0432.ccr-08-0024 · 2008 · External reference
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers
10.1038/s41467-020-16243-3 · 2020 · External reference
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
10.1038/cddis.2011.36 · 2011 · External reference
Tumor cells have decreased ability to metabolize H2O2: implications for pharmacological ascorbate in cancer therapy
10.1016/j.redox.2016.10.010 · 2016 · External reference
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer
10.1158/1078-0432.ccr-09-1713 · 2010 · External reference
Herb-drug interactions in oncology: pharmacodynamic/pharmacokinetic mechanisms and risk prediction
10.1186/s13020-025-01156-4 · 2025 · External reference
Tumor markers in pancreatic cancer: a European Group on tumor Markers (EGTM) status report
10.1093/annonc/mdp332 · 2010 · External reference
Unresolved reference
External reference
Curcumin and gemcitabine in patients with advanced pancreatic cancer
10.1080/01635581.2010.513802 · 2010 · External reference
Curcumin in prostate cancer: a systematic review of molecular mechanisms and nanoformulated therapeutic strategies
10.1186/s12885-025-15152-2 · 2025 · External reference
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
10.1016/j.freeradbiomed.2011.03.007 · 2011 · External reference
A phase II trial of the vitamin D analogue seocalcitol (EB1089) in patients with inoperable pancreatic cancer
10.1038/sj.bjc.6600162 · 2002 · External reference
Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway
10.1186/s12885-024-12715-7 · 2024 · External reference
Improved pancreatic adenocarcinoma diagnosis in jaundiced and non-jaundiced pancreatic adenocarcinoma patients through the combination of routine clinical markers associated to pancreatic adenocarcinoma pathophysiology
10.1371/journal.pone.0147214 · 2016 · External reference
Molecular mechanisms of pancreatic carcinogenesis
10.1111/j.1349-7006.2005.00134.x · 2006 · External reference
Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans
10.1155/2015/837042 · 2015 · External reference
Therapeutic potential and underlying mechanisms of phytoconstituents: emphasizing on resveratol, curcumin, quercetin, berberine, and hesperidin in ulcerative colitis
10.1007/s00210-025-03811-x · 2025 · External reference
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer
10.1002/ijc.22790 · 2007 · External reference
Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK
10.3967/bes2013.019 · 2013 · External reference
Mutant p53, stabilized by its interplay with HSP90, activates a positive feed-back loop between NRF2 and p62 that induces chemo-resistance to apigenin in pancreatic cancer cells
10.3390/cancers11050703 · 2019 · External reference
Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows
10.1210/endrev/bnae009 · 2024 · External reference
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
10.1186/s12904-019-0494-6 · 2019 · External reference
A pilot study of paricalcitol plus nanoliposomal irinotecan and 5-FU/LV in advanced pancreatic cancer patients after progression on gemcitabine-based therapy
10.1158/1078-0432.ccr-23-1405 · 2023 · External reference
Vitamin D and pancreatic ductal adenocarcinoma—A review of a complicated relationship
10.3390/nu16234085 · 2024 · External reference
Vitamin D promotes ferroptosis in colorectal cancer stem cells via SLC7A11 downregulation
10.1155/2023/4772134 · 2023 · External reference
Chemosensitization of tumors by resveratrol
10.1111/j.1749-6632.2010.05852.x · 2011 · External reference
Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: final results of the international phase III LAP 07 study
10.1200/jco.2013.31.18_suppl.lba4003 · 2013 · External reference
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
10.1186/s13063-020-04541-6 · 2020 · External reference
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer
10.1002/ijc.25041 · 2010 · External reference
The therapeutic potential of natural products for treating pancreatic cancer
10.3389/fphar.2022.1051952 · 2022 · External reference
The effect of resveratrol and quercetin on epithelial-mesenchymal transition in pancreatic cancer stem cell
10.1080/01635581.2019.1670853 · 2020 · External reference
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
10.1093/ajcn/80.6.1678s · 2004 · External reference
Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline
10.1210/jc.2011-0385 · 2011 · External reference
Therapeutic potential of curcumin in treatment of pancreatic cancer: current status and future perspectives
10.1002/jcb.25897 · 2017 · External reference
Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells
10.2147/ott.s91511 · 2015 · External reference
Regulation of tumor microenvironment for pancreatic cancer therapy
10.1016/j.biomaterials.2021.120680 · 2021 · External reference
Luteolin, a flavonoid, as an anticancer agent: a review
10.1016/j.biopha.2019.108612 · 2019 · External reference
T cell recognition of human tumors: implications for molecular immunotherapy of cancer
10.1006/clin.1993.1012 · 1993 · External reference
The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: a double-blind, randomized controlled trial
10.1080/07315724.2016.1140093 · 2017 · External reference
Nimbolide: a potential phytochemical agent in multimodal pancreatic cancer therapies
10.2174/0113895575293138240527061556 · 2025 · External reference
Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade
10.1002/mnfr.201300307 · 2013 · External reference
Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro
10.1016/j.fct.2013.07.036 · 2013 · External reference
Luteolin and gemcitabine protect against pancreatic cancer in an orthotopic mouse model
10.1097/mpa.0000000000000215 · 2015 · External reference
Unresolved reference
External reference
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
10.1007/s00280-010-1470-2 · 2011 · External reference
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients
10.1007/s00280-013-2151-8 · 2013 · External reference
The antitumor activities of flavonoids
2005 · External reference
DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer
10.1093/carcin/bgab017 · 2021 · External reference
Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines
10.1038/bjc.1997.479 · 1997 · External reference
Pain as a predictor of outcome in patients with operable pancreatic carcinoma
10.1016/s0039-6060(97)90264-6 · 1997 · External reference
Potentially curable pancreatic adenocarcinoma: ASCO clinical practice guideline update
10.1200/jco.19.00946 · 2019 · External reference
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population
10.1111/j.1440-1746.2004.03219.x · 2004 · External reference
Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover
10.1016/j.biocel.2016.07.033 · 2016 · External reference
Vitamin C suppresses pancreatic carcinogenesis through the inhibition of both glucose metabolism and wnt signaling
10.3390/ijms232012249 · 2022 · External reference
Overall survival results from the POLO trial: a phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer
10.1200/jco.21.01604 · 2022 · External reference
Evidence for activation of mutated p53 by apigenin in human pancreatic cancer
10.1016/j.bbamcr.2011.12.008 · 2012 · External reference
Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain
10.1111/bph.13887 · 2017 · External reference
The role of resveratrol in cancer therapy
10.3390/ijms18122589 · 2017 · External reference
Design and synthesis of cannabinoid 1 receptor (CB1R) allosteric modulators: drug discovery applications
10.1016/bs.mie.2017.06.018 · 2017 · External reference
Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells
10.1016/j.canlet.2017.10.029 · 2018 · External reference
Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects
10.2165/11531820-000000000-00000 · 2010 · External reference
Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells
10.1016/j.jfda.2019.07.001 · 2019 · External reference
Vitamin D metabolism
10.1111/j.1529-8019.2009.01286.x · 2010 · External reference
Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis
10.1002/cncr.20605 · 2004 · External reference
The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
10.1039/c8fo00033f · 2018 · External reference
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer
10.1126/sciadv.adg7752 · 2023 · External reference
The synthesis and bioactivity of apigenin derivatives
10.1016/j.fitote.2024.106228 · 2024 · External reference
Improving quercetin bioavailability: a systematic review and meta-analysis of human intervention studies
10.1016/j.foodchem.2025.143630 · 2025 · External reference
The endocannabinoid system: a potential target for the treatment of various diseases
10.3390/ijms22179472 · 2021 · External reference
Hereditary pancreatitis and the risk of pancreatic cancer. International hereditary pancreatitis study group
10.1093/jnci/89.6.442 · 1997 · External reference
Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells
10.1016/j.toxlet.2014.09.014 · 2014 · External reference
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
10.1016/j.annonc.2022.05.519 · 2022 · External reference
Clinical effects of curcumin in enhancing cancer therapy: a systematic review
10.1186/s12885-020-07256-8 · 2020 · External reference
The match between molecular subtypes, histology and microenvironment of pancreatic cancer and its relevance for chemoresistance
10.3390/cancers13020322 · 2021 · External reference
Unresolved reference
External reference
Nimbolide inhibits SOD2 to control pancreatic ductal adenocarcinoma growth and metastasis
10.3390/antiox12101791 · 2023 · External reference
Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells
10.1016/j.jss.2010.10.041 · 2011 · External reference
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
10.1371/journal.pone.0029794 · 2012 · External reference
Flavonoid derivative of cannabis demonstrates therapeutic potential in preclinical models of metastatic pancreatic cancer
10.3389/fonc.2019.00660 · 2019 · External reference
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
10.1016/s1470-2045(13)70021-4 · 2013 · External reference
Pharmacological vitamin C-induced high H2O2 generation mediates apoptotic cell death by caspase 3/7 activation in breast cancer tumor spheroids
10.1186/s12967-024-06016-7 · 2025 · External reference
Pancreatic Cancer
10.1016/s0140-6736(10)62307-0 · 2018 · External reference
ESPAC-4: a multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: five year follow-up
10.1200/jco.2020.38.15_suppl.4516 · 2020 · External reference
Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs
10.1080/15384101.2015.1127471 · 2016 · External reference
Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl
10.18632/oncotarget.11122 · 2016 · External reference
Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer
10.1186/s12943-017-0589-8 · 2017 · External reference
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic CancerA randomized controlled trial
10.1001/jama.297.3.267 · 2007 · External reference
FOLFIRINOX or gemcitabine plus nab-paclitaxel as first line treatment in pancreatic cancer: a real-world comparison
10.21873/cdp.10303 · 2024 · External reference
Rethinking nature’s pharmacy: AI era and natural product drug discovery
10.3390/ph19020301 · 2026 · External reference
SH003 as a redox-immune modulating phytomedicine: a ferroptosis induction, exosomal crosstalk, and translational oncology perspective
10.3390/cancers17213519 · 2025 · External reference
Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells
2010 · External reference
Structure and the anticancer activity of vitamin D receptor agonists
10.3390/ijms25126624 · 2024 · External reference
Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog signaling pathway
10.3892/mmr.2014.2511 · 2014 · External reference
Calcifediol cornerstone of the vitamin D endocrine system
10.3390/nu15102290 · 2023 · External reference
Cannabinoids, phenolics, terpenes and alkaloids of cannabis
10.3390/molecules26092774 · 2021 · External reference
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States
10.1158/0008-5472.can-14-0155 · 2014 · External reference
Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial
10.1055/s-0042-118705 · 2017 · External reference
Oral quercetin supplementation enhances adiponectin receptor transcript expression in polycystic ovary syndrome patients: a randomized placebo-controlled double-blind clinical trial
10.22074/cellj.2018.4577 · 2018 · External reference
Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity
10.1530/joe-14-0335 · 2014 · External reference
Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors
10.1371/journal.pone.0025166 · 2011 · External reference
Familial pancreatic cancer: genetic advances
10.1101/gad.228452.113 · 2014 · External reference
Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends
10.1016/j.ejphar.2013.06.009 · 2013 · External reference
Innovative preparation of curcumin for improved oral bioavailability
10.1248/bpb.34.660 · 2011 · External reference
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3
10.1093/carcin/bgh086 · 2004 · External reference
19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo
10.4161/cbt.7.3.5418 · 2008 · External reference
Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells
10.1038/sj.onc.1208046 · 2004 · External reference
Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans
10.1016/s0014-5793(98)01304-0 · 1998 · External reference
Apigenin: a promising molecule for cancer prevention
10.1007/s11095-010-0089-7 · 2010 · External reference
Cancer statistics, 2019
10.3322/caac.21551 · 2019 · External reference
Cancer statistics, 2024
10.3322/caac.21820 · 2024 · External reference
Nimbolide-encapsulated PLGA nanoparticles induces mesenchymal-to-epithelial transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells
10.1016/j.tiv.2021.105293 · 2022 · External reference
Vitamin D intake and the risk for pancreatic cancer in two cohort studies
10.1158/1055-9965.epi-06-0206 · 2006 · External reference
Sotorasib in KRAS p.G12C–Mutated advanced pancreatic cancer
10.1056/nejmoa2208470 · 2023 · External reference
Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms
10.7150/thno.35219 · 2019 · External reference
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
10.1016/s1470-2045(22)00541-1 · 2022 · External reference
Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition
10.1038/srep19819 · 2016 · External reference
Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model
10.1016/j.freeradbiomed.2014.07.034 · 2014 · External reference
Imaging of pancreatic ductal adenocarcinoma: state of the art
10.4329/wjr.v5.i3.98 · 2013 · External reference
Dietary polyphenols in cancer chemoprevention: implications in pancreatic cancer
10.3390/antiox9080651 · 2020 · External reference
Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest
10.1186/1476-4598-5-76 · 2006 · External reference
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
10.1016/j.ejca.2003.12.004 · 2004 · External reference
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
10.1007/s12094-016-1586-x · 2016 · External reference
Apigenin increases SHIP-1 expression, promotes tumoricidal macrophages and anti-tumor immune responses in Murine pancreatic cancer
10.3390/cancers12123631 · 2020 · External reference
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
10.1016/s0140-6736(23)01366-1 · 2023 · External reference
Elaborating the role of natural products-induced autophagy in cancer treatment: achievements and artifacts in the state of the art
10.1155/2015/934207 · 2015 · External reference
Resveratrol, piceatannol, curcumin, and quercetin as therapeutic targets in gastric cancer—mechanisms and clinical implications for natural products
10.3390/molecules30010003 · 2025 · External reference
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
10.1007/s00280-013-2070-8 · 2013 · External reference
Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Primary and final analysis from the phase 3 RASolute 302 study
10.1200/jco.2026.44.17_suppl.lba5 · 2026 · External reference
Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway
10.1007/978-3-211-73574-9_9 · 2007 · External reference
Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway
10.1016/j.freeradbiomed.2022.09.001 · 2022 · External reference
Regulation of ferroptotic cancer cell death by GPX4
10.1016/j.cell.2013.12.010 · 2014 · External reference
Cannabinoids inhibited pancreatic cancer via P-21 activated kinase 1 mediated pathway
10.3390/ijms21218035 · 2020 · External reference
Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway
10.1016/j.phymed.2021.153575 · 2021 · External reference
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
10.1007/s00415-015-7719-2 · 2015 · External reference
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression
10.1093/carcin/bgx065 · 2017 · External reference
Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
10.2147/ott.s136840 · 2017 · External reference
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
10.1126/science.aaa5004 · 2015 · External reference
Chemoresistance in pancreatic cancer
10.3390/ijms20184504 · 2019 · External reference
Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells
10.18632/genesandcancer.15 · 2014 · External reference
Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH-)
10.7150/thno.35378 · 2019 · External reference
Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway
10.3892/mmr.2015.4060 · 2015 · External reference
The effect of quercetin supplementation on oxidative stress, glycemic control, lipid profile and insulin resistance in type 2 diabetes: a randomized clinical trial
2014 · External reference
Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system
10.3390/ijms19030833 · 2018 · External reference
Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells
10.3892/mmr.2015.4338 · 2015 · External reference
